Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
ATAZANAVIR SULFATE
(2003)
Small molecule
Human immunodeficiency virus type 1 protease inhibitor
ORAL
Approved
HIV Infections; Infections
ATAZANAVIR SULFATE
×
Maximum Phase:
4
First Approval:
2003
UNII:
4MT4VIE29P
Molecule Type:
Small molecule
Molecular Formula:
C38H54N6O11S
Molecular Weight:
802.95
AlogP:
4.21
PSA:
171.22
HBD:
5.0
HBA:
#RotB:
14.0
Source:
GEMIFLOXACIN
(2003)
Small molecule
Unknown
Unknown
Approved
Bacterial Infections
GEMIFLOXACIN
×
Maximum Phase:
4
First Approval:
2003
UNII:
OKR68Y0E4T
Molecule Type:
Small molecule
Molecular Formula:
C18H20FN5O4
Molecular Weight:
389.39
AlogP:
0.97
PSA:
123.04
HBD:
2.0
HBA:
#RotB:
5.0
Source:
CARBINOXAMINE MALEATE
(2003)
Small molecule
Histamine H1 receptor antagonist
ORAL
Approved
Angioedema; Conjunctivitis, Allergic; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Rhinitis, Vasomotor; Urticaria
CARBINOXAMINE MALEATE
×
Maximum Phase:
4
First Approval:
2003
UNII:
02O55696WH
Molecule Type:
Small molecule
Molecular Formula:
C20H23ClN2O5
Molecular Weight:
406.87
AlogP:
3.4
PSA:
25.36
HBD:
0.0
HBA:
#RotB:
6.0
Source:
ALFUZOSIN HYDROCHLORIDE
(2003)
Small molecule
Adrenergic receptor alpha-1 agonist
ORAL
Approved
Prostatic Hyperplasia
ALFUZOSIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2003
UNII:
75046A1XTN
Molecule Type:
Small molecule
Molecular Formula:
C19H28ClN5O4
Molecular Weight:
425.92
AlogP:
1.35
PSA:
111.83
HBD:
2.0
HBA:
#RotB:
8.0
Source:
VARDENAFIL HYDROCHLORIDE
(2003)
Small molecule
Phosphodiesterase 5A inhibitor
ORAL
Approved
Erectile Dysfunction
VARDENAFIL HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2003
UNII:
5M8S2CU0TS
Molecule Type:
Small molecule
Molecular Formula:
C23H33ClN6O4S
Molecular Weight:
525.08
AlogP:
2.07
PSA:
112.9
HBD:
1.0
HBA:
#RotB:
8.0
Source:
MEMANTINE HYDROCHLORIDE
(2003)
Small molecule
Glutamate [NMDA] receptor negative allosteric modulator
ORAL
Approved
Alzheimer Disease; Dementia
MEMANTINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2003
UNII:
JY0WD0UA60
Molecule Type:
Small molecule
Molecular Formula:
C12H22ClN
Molecular Weight:
215.77
AlogP:
2.69
PSA:
26.02
HBD:
1.0
HBA:
#RotB:
0.0
Source:
ALFUZOSIN
(2003)
Small molecule
Unknown
Unknown
Approved
Prostatic Hyperplasia
ALFUZOSIN
×
Maximum Phase:
4
First Approval:
2003
UNII:
90347YTW5F
Molecule Type:
Small molecule
Molecular Formula:
C19H27N5O4
Molecular Weight:
389.46
AlogP:
1.35
PSA:
111.83
HBD:
2.0
HBA:
#RotB:
8.0
Source:
IBANDRONATE SODIUM
(2003)
Small molecule
Farnesyl diphosphate synthase inhibitor
INJECTION; INTRAVENOUS; ORAL
Approved
Osteoporosis; Osteoporosis, Postmenopausal
IBANDRONATE SODIUM
×
Maximum Phase:
4
First Approval:
2003
UNII:
J12U072QL0
Molecule Type:
Small molecule
Molecular Formula:
C9H24NNaO8P2
Molecular Weight:
359.23
AlogP:
0.5
PSA:
138.53
HBD:
5.0
HBA:
#RotB:
9.0
Source:
SERTACONAZOLE NITRATE
(2003)
Small molecule
Cytochrome P450 51 inhibitor
TOPICAL
Approved
Tinea Pedis
SERTACONAZOLE NITRATE
×
Maximum Phase:
4
First Approval:
2003
UNII:
1DV05410M5
Molecule Type:
Small molecule
Molecular Formula:
C20H16Cl3N3O4S
Molecular Weight:
500.79
AlogP:
7.02
PSA:
27.05
HBD:
0.0
HBA:
#RotB:
6.0
Source:
ROSUVASTATIN
(2003)
Small molecule
Unknown
Unknown
Approved
Cardiovascular Diseases
ROSUVASTATIN
×
Maximum Phase:
4
First Approval:
2003
UNII:
413KH5ZJ73
Molecule Type:
Small molecule
Molecular Formula:
C22H28FN3O6S
Molecular Weight:
481.55
AlogP:
2.4
PSA:
140.92
HBD:
3.0
HBA:
#RotB:
10.0
Source:
MIGLUSTAT
(2003)
Small molecule
Ceramide glucosyltransferase inhibitor
ORAL
Approved
Gaucher Disease
MIGLUSTAT
×
Maximum Phase:
4
First Approval:
2003
UNII:
ADN3S497AZ
Molecule Type:
Small molecule
Molecular Formula:
C10H21NO4
Molecular Weight:
219.28
AlogP:
-1.45
PSA:
84.16
HBD:
4.0
HBA:
#RotB:
4.0
Source:
VARDENAFIL
(2003)
Small molecule
Unknown
Unknown
Approved
Erectile Dysfunction
VARDENAFIL
×
Maximum Phase:
4
First Approval:
2003
UNII:
UCE6F4125H
Molecule Type:
Small molecule
Molecular Formula:
C23H32N6O4S
Molecular Weight:
488.61
AlogP:
2.07
PSA:
112.9
HBD:
1.0
HBA:
#RotB:
8.0
Source:
SERTACONAZOLE
(2003)
Small molecule
Unknown
Unknown
Approved
Unknown
SERTACONAZOLE
×
Maximum Phase:
4
First Approval:
2003
UNII:
72W71I16EG
Molecule Type:
Small molecule
Molecular Formula:
C20H15Cl3N2OS
Molecular Weight:
437.78
AlogP:
7.02
PSA:
27.05
HBD:
0.0
HBA:
#RotB:
6.0
Source:
FOSAMPRENAVIR
(2003)
Small molecule
Unknown
Unknown
Approved
Virus Diseases
FOSAMPRENAVIR
×
Maximum Phase:
4
First Approval:
2003
UNII:
WOU1621EEG
Molecule Type:
Small molecule
Molecular Formula:
C25H36N3O9PS
Molecular Weight:
585.62
AlogP:
2.52
PSA:
177.72
HBD:
4.0
HBA:
#RotB:
13.0
Source:
BORTEZOMIB
(2003)
Small molecule
26S proteosome inhibitor
INJECTION; INTRAVENOUS; SUBCUTANEOUS; UNKNOWN
Approved
Lymphoma, Mantle-Cell; Multiple Myeloma; Neoplasms
BORTEZOMIB
×
Maximum Phase:
4
First Approval:
2003
UNII:
69G8BD63PP
Molecule Type:
Small molecule
Molecular Formula:
C19H25BN4O4
Molecular Weight:
384.25
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ESTRADIOL ACETATE
(2003)
Small molecule
Estrogen receptor alpha agonist
ORAL; VAGINAL
Approved
Atrophy; Menopause
ESTRADIOL ACETATE
×
Maximum Phase:
4
First Approval:
2003
UNII:
5R97F5H93P
Molecule Type:
Small molecule
Molecular Formula:
C20H26O3
Molecular Weight:
314.43
AlogP:
3.83
PSA:
46.53
HBD:
1.0
HBA:
#RotB:
1.0
Source:
PALONOSETRON
(2003)
Small molecule
Unknown
Unknown
Approved
Nausea
PALONOSETRON
×
Maximum Phase:
4
First Approval:
2003
UNII:
5D06587D6R
Molecule Type:
Small molecule
Molecular Formula:
C19H24N2O
Molecular Weight:
296.41
AlogP:
2.66
PSA:
23.55
HBD:
0.0
HBA:
#RotB:
1.0
Source:
OMEPRAZOLE MAGNESIUM
(2003)
Small molecule
Potassium-transporting ATPase inhibitor
Unknown
Approved
Unknown
OMEPRAZOLE MAGNESIUM
×
Maximum Phase:
4
First Approval:
2003
UNII:
426QFE7XLK
Molecule Type:
Small molecule
Molecular Formula:
C34H36MgN6O6S2
Molecular Weight:
713.14
AlogP:
2.9
PSA:
77.1
HBD:
1.0
HBA:
#RotB:
5.0
Source:
MEMANTINE
(2003)
Small molecule
Unknown
Unknown
Approved
Dementia
MEMANTINE
×
Maximum Phase:
4
First Approval:
2003
UNII:
W8O17SJF3T
Molecule Type:
Small molecule
Molecular Formula:
C12H21N
Molecular Weight:
179.31
AlogP:
2.69
PSA:
26.02
HBD:
1.0
HBA:
#RotB:
0.0
Source:
GEFITINIB
(2003)
Small molecule
Epidermal growth factor receptor erbB1 inhibitor
ORAL
Approved
Carcinoma, Non-Small-Cell Lung; Neoplasms
GEFITINIB
×
Maximum Phase:
4
First Approval:
2003
UNII:
S65743JHBS
Molecule Type:
Small molecule
Molecular Formula:
C22H24ClFN4O3
Molecular Weight:
446.91
AlogP:
4.28
PSA:
68.74
HBD:
1.0
HBA:
#RotB:
8.0
Source:
EMTRICITABINE
(2003)
Small molecule
Human immunodeficiency virus type 1 reverse transcriptase inhibitor
ORAL
Approved
HIV Infections; Virus Diseases
EMTRICITABINE
×
Maximum Phase:
4
First Approval:
2003
UNII:
G70B4ETF4S
Molecule Type:
Small molecule
Molecular Formula:
C8H10FN3O3S
Molecular Weight:
247.25
AlogP:
-0.46
PSA:
90.37
HBD:
2.0
HBA:
#RotB:
2.0
Source:
GEMIFLOXACIN MESYLATE
(2003)
Small molecule
DNA gyrase inhibitor
ORAL
Approved
Unknown
GEMIFLOXACIN MESYLATE
×
Maximum Phase:
4
First Approval:
2003
UNII:
X4S9F8RL01
Molecule Type:
Small molecule
Molecular Formula:
C19H24FN5O7S
Molecular Weight:
485.49
AlogP:
0.97
PSA:
123.04
HBD:
2.0
HBA:
#RotB:
5.0
Source:
PRUSSIAN BLUE INSOLUBLE
(2003)
Small molecule
Radioactive metals chelating agent
Unknown
Approved
Unknown
PRUSSIAN BLUE INSOLUBLE
×
Maximum Phase:
4
First Approval:
2003
UNII:
TLE294X33A
Molecule Type:
Small molecule
Molecular Formula:
C18Fe7N18
Molecular Weight:
859.24
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
CARBINOXAMINE
(2003)
Small molecule
Unknown
Unknown
Approved
Hypersensitivity
CARBINOXAMINE
×
Maximum Phase:
4
First Approval:
2003
UNII:
982A7M02H5
Molecule Type:
Small molecule
Molecular Formula:
C16H19ClN2O
Molecular Weight:
290.79
AlogP:
3.4
PSA:
25.36
HBD:
0.0
HBA:
#RotB:
6.0
Source:
ROSUVASTATIN CALCIUM
(2003)
Small molecule
HMG-CoA reductase inhibitor
ORAL
Approved
Atherosclerosis; Coronary Artery Disease; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III
ROSUVASTATIN CALCIUM
×
Maximum Phase:
4
First Approval:
2003
UNII:
83MVU38M7Q
Molecule Type:
Small molecule
Molecular Formula:
C44H54CaF2N6O12S2
Molecular Weight:
1001.15
AlogP:
2.4
PSA:
140.92
HBD:
3.0
HBA:
#RotB:
10.0
Source:
METHYL AMINOLEVULINATE
(2004)
Small molecule
Unknown
Unknown
Approved
Neoplasms
METHYL AMINOLEVULINATE
×
Maximum Phase:
4
First Approval:
2004
UNII:
585NM85KYM
Molecule Type:
Small molecule
Molecular Formula:
C6H11NO3
Molecular Weight:
145.16
AlogP:
-0.53
PSA:
69.39
HBD:
1.0
HBA:
#RotB:
4.0
Source:
DARIFENACIN HYDROBROMIDE
(2004)
Small molecule
Muscarinic acetylcholine receptor M2 antagonist
ORAL
Approved
Urinary Bladder, Overactive; Urinary Incontinence, Urge
DARIFENACIN HYDROBROMIDE
×
Maximum Phase:
4
First Approval:
2004
UNII:
CR02EYQ8GV
Molecule Type:
Small molecule
Molecular Formula:
C28H31BrN2O2
Molecular Weight:
507.47
AlogP:
3.96
PSA:
55.56
HBD:
1.0
HBA:
#RotB:
7.0
Source:
ACAMPROSATE CALCIUM
(2004)
Small molecule
GABA-A receptor; anion channel positive modulator
ORAL
Approved
Alcoholism
ACAMPROSATE CALCIUM
×
Maximum Phase:
4
First Approval:
2004
UNII:
59375N1D0U
Molecule Type:
Small molecule
Molecular Formula:
C10H20CaN2O8S2
Molecular Weight:
400.49
AlogP:
-0.6
PSA:
83.47
HBD:
2.0
HBA:
#RotB:
4.0
Source:
PEMETREXED DISODIUM
(2004)
Small molecule
Dihydrofolate reductase inhibitor
INJECTION; INTRAVENOUS
Approved
Carcinoma, Non-Small-Cell Lung
PEMETREXED DISODIUM
×
Maximum Phase:
4
First Approval:
2004
UNII:
2PKU919BA9
Molecule Type:
Small molecule
Molecular Formula:
C20H19N5Na2O6
Molecular Weight:
471.38
AlogP:
0.67
PSA:
191.26
HBD:
6.0
HBA:
#RotB:
9.0
Source:
GLUTAMINE
(2004)
Small molecule
Unknown
Unknown
Approved
Anemia, Sickle Cell; Short Bowel Syndrome
GLUTAMINE
×
Maximum Phase:
4
First Approval:
2004
UNII:
0RH81L854J
Molecule Type:
Small molecule
Molecular Formula:
C5H10N2O3
Molecular Weight:
146.15
AlogP:
-1.34
PSA:
106.41
HBD:
3.0
HBA:
#RotB:
4.0
Source:
BISACODYL
(2004)
Small molecule
Unknown
Unknown
Approved
Constipation
BISACODYL
×
Maximum Phase:
4
First Approval:
2004
UNII:
10X0709Y6I
Molecule Type:
Small molecule
Molecular Formula:
C22H19NO4
Molecular Weight:
361.4
AlogP:
4.11
PSA:
65.49
HBD:
0.0
HBA:
#RotB:
5.0
Source:
TIOTROPIUM
(2004)
Small molecule
Unknown
Unknown
Approved
Unknown
TIOTROPIUM
×
Maximum Phase:
4
First Approval:
2004
UNII:
0EB439235F
Molecule Type:
Small molecule
Molecular Formula:
C19H22NO4S2+
Molecular Weight:
392.52
AlogP:
2.35
PSA:
59.06
HBD:
1.0
HBA:
#RotB:
4.0
Source:
RIFAXIMIN
(2004)
Small molecule
Bacterial DNA-directed RNA polymerase inhibitor
ORAL
Approved
Diarrhea; Hepatic Encephalopathy; Infections
RIFAXIMIN
×
Maximum Phase:
4
First Approval:
2004
UNII:
L36O5T016N
Molecule Type:
Small molecule
Molecular Formula:
C43H51N3O11
Molecular Weight:
785.89
AlogP:
6.16
PSA:
198.38
HBD:
5.0
HBA:
#RotB:
2.0
Source:
PEMETREXED
(2004)
Small molecule
Unknown
INJECTION; INTRAVENOUS; IV (INFUSION)
Approved
Mesothelioma; Neoplasms
PEMETREXED
×
Maximum Phase:
4
First Approval:
2004
UNII:
04Q9AIZ7NO
Molecule Type:
Small molecule
Molecular Formula:
C20H21N5O6
Molecular Weight:
427.42
AlogP:
0.67
PSA:
191.26
HBD:
6.0
HBA:
#RotB:
9.0
Source:
PENTETATE ZINC TRISODIUM
(2004)
Small molecule
Radioactive metals chelating agent
INHALATION; INTRAVENOUS
Approved
Unknown
PENTETATE ZINC TRISODIUM
×
Maximum Phase:
4
First Approval:
2004
UNII:
NXU65IC8PG
Molecule Type:
Small molecule
Molecular Formula:
C14H18N3Na3O10Zn
Molecular Weight:
522.67
AlogP:
-2.68
PSA:
196.22
HBD:
5.0
HBA:
#RotB:
16.0
Source:
ERLOTINIB HYDROCHLORIDE
(2004)
Small molecule
Epidermal growth factor receptor erbB1 inhibitor
ORAL
Approved
Carcinoma, Non-Small-Cell Lung
ERLOTINIB HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2004
UNII:
DA87705X9K
Molecule Type:
Small molecule
Molecular Formula:
C22H24ClN3O4
Molecular Weight:
429.9
AlogP:
3.41
PSA:
74.73
HBD:
1.0
HBA:
#RotB:
10.0
Source:
1
2
…
53
54
55
56
57
58
59
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA